Michael A. Rogawski MD 1980, PhD 1980
Michael, a Professor of Neurology and Pharmacology at University of California-Davis, wrote to "update you on a major event in my life and one that will hopefully impact the lives of many, many women in a positive way. I discovered a new treatment [the neuroactive steroid allopregnanolone] for postpartum depression that was recently approved by the FDA." Allopregnanolone (also known as brexanolone) is the first drug approved by the FDA for postpartum depression which affects approximately 2 out of 9 women who have given birth in the U.S. Read the full press release here: https://health.ucdavis.edu/publish/news/neurology/13753
Jerome Chin MD 1988, PhD 1987
Since 2010 I have been extensively involved in global health and international neurology. My research interests include the determinants and prevention of stroke in developing countries, the neurology of HIV/AIDS, and central nervous system tuberculosis. I am a visiting faculty member at Mulago National Referral Hospital in Kampala, Uganda and Muhumbili University of Health and Allied Sciences in Dar es Salaam, Tanzania where I teach neurology to medical students, interns, and residents for two months every year. I joined the Department of Neurology at NYU Langone Health as an adjunct professor in August 2015. I attend on the neurology inpatient service at Bellevue Hospital in New York City. Senior NYU neurology residents have the opportunity to join me and Dr. Jaydeep Bhatt during these teaching visits. In 2012 I founded the Alliance for Stroke Awareness and Prevention Project (www.asapp.org), a non-profit volunteer-led initiative providing free weekly screening and counseling for high blood pressure and diabetes at places of religious worship in Uganda, Tanzania, India, and Nepal. I am a fellow of the American Academy of Neurology, as well as chair of the academy’s International Subcommittee, a member of the Sections Subcommittee, and past and founding chair of its Global Health Section.
Louis Marotti MD 2002, PhD 2002
Voted #1 Surgeon 2017 Lancaster County Magazine Readers Survey. Argires Marotti Neurosurgical Associates of Lancaster voted #1 Neurosurgical Practice 2017 Lancaster County Magazine Readers Survey.
Peter Ho MD 1990, PhD 1990
Peter joined Boston Pharmaceuticals in 2018 from Epizyme, where as Chief Medical Officer he led the company’s clinical development, translational research and regulatory affairs functions. Prior to Epizyme, Peter was Co-Founder and President of BeiGene Ltd. His previous pharmaceutical positions included Vice President of Oncology Clinical Development at Johnson and Johnson and Senior Vice President of the Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline. Peter began his career in drug discovery and development at the Investigational Drug Branch of the Cancer Therapy Evaluation Program, National Cancer Institute (NCI) followed by positions of increasing responsibility at Novartis and DuPont Pharmaceuticals. Over my career in drug discovery and drug development at the NCI, FDA, and in the pharmaceutical industry, I have been directly responsible for the first-in-human dosing of 18 anticancer agents and have overseen the development of over 60 investigational compounds. This has led to 10 regulatory approvals to date of small molecule and biologics drugs including Gleevec®; Arranon®; Tykerb®; Promacta®; Votrient®; Synribo®; Tafinlar®; Mekinist®; Sylvant®, and Rydap®.